Literature DB >> 11910281

Hypertension and the risk of cancer: is there new evidence?

Klaus O Stumpe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11910281     DOI: 10.1097/00004872-200204000-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  5 in total

1.  The impact of metabolic syndrome on outcome and response to neoadjuvant chemoradiation in locally advanced rectal cancer patients.

Authors:  Brandon J Anderson; Amy E Wahlquist; Elizabeth G Hill; David T Marshall; Eric T Kimchi; Kevin F Staveley O'Carroll; E Ramsay Camp
Journal:  Int J Surg       Date:  2016-07-16       Impact factor: 6.071

2.  Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study.

Authors:  Tsogzolmaa Dorjgochoo; Xiao Ou Shu; Xianglan Zhang; Honglan Li; Gong Yang; Lifeng Gao; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

3.  Effect of hypertension on outcomes of high-risk patients after BCG-treated bladder cancer: a single-institution long follow-up cohort study.

Authors:  Fabrizio Dal Moro; Alberto Bovo; Alessandro Crestani; Roberto Vettor; Marina P Gardiman; Filiberto Zattoni
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

4.  The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.

Authors:  Nan Sha; Hao Xu; Tao Chen; Da-Wei Tian; Wan-Qin Xie; Lin-Guo Xie; Yu Zhang; Chen Xing; Xiao-Teng Liu; Zhong-Hua Shen; Zhou-Liang Wu; Hai-Long Hu; Chang-Li Wu
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

5.  Sex-specific clustering of metabolic risk factors and cancer risk: a longitudinal study in Iran.

Authors:  Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh
Journal:  Biol Sex Differ       Date:  2020-04-25       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.